Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant Complement C4d anticorps

L’anticorps anti-Complement C4d Monoclonal Lapin est utilisé pour la détection de Complement C4d dans des échantillons de Humain. Il a été validé pour ELISA, IHC et WB.
N° du produit ABIN7863829
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant Complement C4d anticorps (ABIN7863829)

Antigène

Complement C4d (C4d) (Complement Component C4d (C4d))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 39
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 29
  • 12
Lapin

Clonalité

  • 33
  • 8
Monoclonal

Conjugué

  • 23
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp Complement C4d est non-conjugé

Application

  • 22
  • 21
  • 15
  • 14
  • 12
  • 10
  • 9
  • 7
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC), Western Blotting (WB)

Clone

C4D-9213R
  • Fonction

    Recombinant Complement 4d (C4d) (Acute Humoral Rejection Marker) Antibody

    Specificité

    This MAb is specific to Complement 4d (C4d) and reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 Molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant full-length human Complement 4d protein

    Isotype

    IgG, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    Complement C4d (C4d) (Complement Component C4d (C4d))

    Autre désignation

    Complement 4d

    Sujet

    Acidic Complement C4, Basic C4, C4-1, C4a Anaphylatoxin, C4A, C4A2, C4A3, C4A4, C4A6, C4b, C4B1, C4B12, C4d fragment, C4F, C4S, Complement C4 Gamma Chain, Complement Component 4A, Complement Component 4B

    Rejected Renal Transplant Tissue

    Poids moléculaire

    192kDa (predicted)

    ID gène

    720, 721

    UniProt

    P0C0L4, P0C0L5
Vous êtes ici:
Chat with us!